Drugs Archives - Page 13 of 65

Debt Deal Leaves Health Programs (Mostly) Intact

Episode 301

June 7, 2023

The bipartisan deal to extend the U.S. government’s borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program’s new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Sarah Jane Tribble, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about the perils of visiting the U.S. with European health insurance.

Listen Now

A woman in a red blouse with short sleeves stands in a doorway with her hand on one side of the frame and looks at the camera.

Diagnosis: Debt

Many People Living in the ‘Diabetes Belt’ Are Plagued With Medical Debt

The “Diabetes Belt,” as defined by the Centers for Disease Control and Prevention, comprises 644 mostly Southern counties where diabetes rates are high. Of those counties, KFF Health News and NPR found, more than half also have high levels of medical debt.

By Robert Benincasa, NPR and Nick McMillan, NPR

May 30, 2023

What the Health? From KFF Health News

When an Anti-Vaccine Activist Runs for President

Episode 299

May 25, 2023

Robert F. Kennedy Jr.’s official entry into the presidential race poses a thorny challenge for journalists: how to cover a candidate who’s opposed to vaccines without amplifying misinformation. And South Carolina becomes the latest state in the South to ban abortion after roughly six weeks of pregnancy. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Aneri Pattani about her project to track the billions of dollars coming from opioid makers to settle lawsuits.

Listen Now

An illustration of three pill capsules filled with dollar bills.

This Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky.

Colorado’s new Prescription Drug Affordability Board could cap what health plans and consumers pay for certain medications starting next year. The process will pit patient groups against one another.

By Markian Hawryluk

May 25, 2023

A photo of packages of pills on a conveyor belt in a factory.

A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen

Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.

By Arthur Allen

May 22, 2023

KFF Health News & PolitiFact HealthCheck

Are US Prescription Drug Prices 10 Times Those of Other Nations? Only Sometimes

Sen. Bernie Sanders’ broad statement that some U.S. drug prices are 10 times those of other nations doesn’t paint the full picture. Studies we examined generally found that U.S. prices were two to four times those in other countries, not 10.

By Michelle Andrews

May 19, 2023

A wooden picnic table has paper sand brochures laid out on the table and a bench. A banner reading "Greene County Anti-Drug Coalition" hangs on a raining behind the table.

Payback: Tracking Opioid Cash

A Rural County’s Choice: Use Opioid Funds to Pay Off Debt, or Pay Them Forward to Curb Crisis

Greene County, Tennessee, so far has received more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But most of the money is not going to help people and families harmed by addiction.

By Aneri Pattani

May 16, 2023

What the Health? From KFF Health News

The Crisis Is Officially Ending, but Covid Confusion Lives On

Episode 297

May 11, 2023

The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.

Listen Now

A photo of a line of health industry executives sitting next to each other during a Senate HELP Committee hearing.

PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention

Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?

By Arthur Allen

May 11, 2023

A man with facial hair wearing a baseball cap and dark tshirt sits on a couch facing the camera.

California Confronts Overdose Epidemic Among Former Prison Inmates

Individuals newly released from prison are 40 times as likely to die of opioid overdoses than members of the general population, researchers say. In response, California corrections officials aim to arm departing inmates with an antidote that can be used to reverse the effects of opioid poisoning.

By Don Thompson

May 10, 2023

Colorado Becomes the First State to Ban So-Called Abortion Pill Reversals

The controversial practice of administering progesterone to people after they have taken the abortion pill mifepristone may be coming to an end in Colorado. Pills have emerged as the latest front in the war over abortion since the U.S. Supreme Court overturned Roe v. Wade last summer.

By Claire Cleveland

May 4, 2023

An older woman sits in a darkened room and is illuminated by light through a window.

Payback: Tracking Opioid Cash

Listen: How Are States Spending Money From the Opioid Settlements? It’s Not Easy to Know

KFF Health News senior correspondent Aneri Pattani appeared on NPR’s “1A” on May 1 to discuss issues related to how opioid settlement funds are being distributed.

May 1, 2023

KFF Health News On Air

Listen: Mifepristone Remains Available for Now. What Happens Next?

The Supreme Court on April 21 ruled that the abortion pill mifepristone should remain widely available while the lower courts consider the issue, blocking earlier rulings that banned or restricted access to the drug. KFF Health News’ Julie Rovner joined NPR’s “Weekend All Things Considered” to discuss the complicated case.

April 24, 2023

A photo illustration of athletes Justin Renfrow, Riley Cote, and Mike Lee surrounded by psychedelic mushrooms.

Pain, Hope, and Science Collide as Athletes Turn to Magic Mushrooms

A group of former professional athletes traveled to Jamaica to try psychedelics as a way to help cope with the aftereffects of concussions and a career of body-pounding injuries. Will this still largely untested treatment work?

By Markian Hawryluk and Kevin Van Valkenburg, ESPN

April 24, 2023

A photo shows a woman wiping away tears while speaking to Joe Biden at an event. She is holding a young girl in her arms.

Payback: Tracking Opioid Cash

The Biden Administration Vowed to Be a Leading Voice on Opioid Settlements But Has Gone Quiet

Billions of dollars are headed to state and local governments to address the opioid crisis. Policy experts and advocates expect the federal government to play a role in overseeing the use of the money. Failure to do so, they say, could lead to wasted opportunities. And, since Medicaid helps pay health care costs, the feds could have a claim to portions of states’ opioid settlements.

By Aneri Pattani

April 21, 2023

What the Health? From KFF Health News

Will They or Won’t They (Block the Abortion Pill)?

Episode 294

April 20, 2023

The Supreme Court is considering the future of the abortion pill mifepristone, after GenBioPro sued the FDA over limitations that effectively block generic production of the drug, a major part of the market. Congress is considering proposals that would impose Medicaid work requirements, crack down on pharmacy benefit managers, and more. And President Joe Biden moved to expand health coverage to young immigrants known as “Dreamers.” Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Mary Agnes Carey to discuss these issues and more.

Listen Now

Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

By Darius Tahir and Hannah Norman

April 18, 2023

KFF Health News On Air

Journalists Track Opioid Settlement Cash and Fees for Telehealth Visits

KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

April 15, 2023

What the Health? From KFF Health News

The Confusing Fate of the Abortion Pill

Episode 293

April 13, 2023

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

Listen Now

A photo of Horizon Therapeutics' CEO speaking at an event.

The Drug Company That Prospered Without Creating Any Drugs

Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

By Arthur Allen

April 13, 2023

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs